Barucainide

This classification denotes an antiarrhythmic agent with the molecular formula C22H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 14NFL30YOH, chemically known as 4-((1,3-dihydro-6-methyl-4-benzylfuro(3,4-c)pyridin-7-yl)oxy)-n-isopropylbutylamine monohydrochloride but more generally known as barucainide, which bears US NIH Compound Identifier 146794. European Medicines Agency schedules Barucainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06106MIG. The term BARUCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). BARUCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule barucainide under HS 29349990 and SITC 51579. As of Q4 2014, BARUCAINIDE remains US FDA's Preferred Term for this commodity. Barucainide bears US NLM identifiers UMLS ID C0052988 and NCI Concept Code C72575. SMILES: CL.O1CC2C(C1)C(NC(C2OCCCCNC(C)C)C)CC1CCCCC1.